Q32 Bio Inc. (LON:0T6G)
3.591
+0.031 (0.88%)
Feb 12, 2026, 3:28 PM GMT
Q32 Bio Employees
Q32 Bio had 26 employees as of September 30, 2025. The number of employees decreased by 17 or -39.53% compared to the same quarter last year.
Employees
26
Change
-17
Growth
-39.53%
Revenue / Employee
n/a
Profits / Employee
-1.20M GBP
Market Cap
34.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 26 | -17 | -39.53% | 26 | 0 |
| Jun 30, 2025 | 28 | -15 | -34.88% | 27 | 1 |
| Mar 31, 2025 | 29 | -10 | -25.64% | 28 | 1 |
| Dec 31, 2024 | 43 | 6 | 16.22% | 42 | 1 |
| Sep 30, 2024 | 43 | 8 | 22.86% | 42 | 1 |
| Jun 30, 2024 | 43 | 8 | 22.86% | 41 | 2 |
| Mar 31, 2024 | 39 | - | - | 39 | 0 |
| Dec 31, 2023 | 37 | - | - | 37 | 0 |
| Sep 30, 2023 | 35 | - | - | 35 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Kooth | 593 |
| hVIVO | 301 |
| Poolbeg Pharma | 16 |
| ImmuPharma | 6 |
Q32 Bio News
- 2 months ago - Insider Sell: Lee Kalowski Sells Shares of Q32 Bio Inc (QTTB) - GuruFocus
- 2 months ago - Q32 Bio Sells Complement Inhibitor ADX-097 To Akebia Therapeutics - Nasdaq
- 2 months ago - Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
- 2 months ago - Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga
- 2 months ago - Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga
- 2 months ago - Q32 Bio Sells Complement Inhibitor ADX-097 - PRNewsWire
- 3 months ago - Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata - PRNewsWire